Sun Pharma to Invest $100 Million in Niche Product Commercialization for FY26
Sun Pharmaceutical Industries Ltd., India’s largest drugmaker, has announced a $100 million investment to commercialize innovative specialty products in the current fiscal year. The move aims to strengthen its patented product portfolio, focusing on oncology and dermatology treatments. Key Highlights of Sun Pharma’s Expansion Impact on India’s Pharmaceutical Industry Sun Pharma’s aggressive expansion in specialty…
